Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.

Name: Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
License: Public Domain

Biogenea Pharmaceuticals Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

glioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127594
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.